ALK Abell Financials

ALK Abell Stock Summary

ALK Abell competes with Defence Therapeutics, Aileron Therapeutics, and Enlivex Therapeutics. ALK-Abell AS operates as an allergy solutions company in Europe, North America, and internationally. ALK-Abell AS was founded in 1923 and is headquartered in Hrsholm, Denmark. Alk Abello operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2587 people.

ALK Abell Key Financial Ratios

There are many critical financial ratios that ALK Abell's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that ALK Abell AS reports annually and quarterly.

ALK Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ALK Abell's current stock value. Our valuation model uses many indicators to compare ALK Abell value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ALK Abell competition to find correlations between indicators driving ALK Abell's intrinsic value. More Info.ALK Abell AS is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.58  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ALK Abell AS is roughly  1.74 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ALK Abell's earnings, one of the primary drivers of an investment's value.

ALK Abell AS Systematic Risk

Along with financial statement analysis, the daily predictive indicators of ALK Abell help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ALK Abell AS. We use our internally-developed statistical techniques to arrive at the intrinsic value of ALK Abell AS based on widely used predictive technical indicators. In general, we focus on analyzing ALK Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ALK Abell's daily price indicators and compare them against related drivers.

When running ALK Abell's price analysis, check to measure ALK Abell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ALK Abell is operating at the current time. Most of ALK Abell's value examination focuses on studying past and present price action to predict the probability of ALK Abell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ALK Abell's price. Additionally, you may evaluate how the addition of ALK Abell to your portfolios can decrease your overall portfolio volatility.